PFG
ABBV icon

Putney Financial Group’s AbbVie ABBV Stock Holding History

Putney Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$929K Sell
3,693
-4,045
-52% -$870K 0.84% 24
2026
Q1 		$1.68M Sell
7,738
-50
-0.6% -$11.1K 1.7% 9
2025
Q4 		$1.78M Buy
7,788
+3,449
+79% +$786K 1.66% 11
2025
Q3 		$1M Buy
4,339
+91
+2% +$18.5K 1% 22
2025
Q2 		$789K Sell
4,248
-123
-3% -$22.9K 0.8% 24
2025
Q1 		$916K Sell
4,371
-41
-0.9% -$7.97K 0.96% 22
2024
Q4 		$784K Buy
+4,412
New +$811K 0.7% 23

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Putney Financial Group's ABBV Position: Q2 2026 in Review

Putney Financial Group reduced its AbbVie (ABBV) stake by 52% in Q2 2026, selling an estimated $870K and leaving 3,693 shares worth $929K. The position accounts for 0.84% of the portfolio, ranked #24.

Putney Financial Group first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.78M in Q4 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Putney Financial Group held 3,693 shares of AbbVie worth $929K as of Q2 2026.
  • Putney Financial Group sold 4,045 AbbVie shares in Q2 2026, an estimated $870K.
  • AbbVie made up 0.84% of Putney Financial Group's portfolio in Q2 2026, its #24 holding.
  • Putney Financial Group first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Putney Financial Group's AbbVie position peaked at $1.78M in Q4 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Putney Financial Group's 13F filing for Q2 2026, filed 21 Jul 2026.